136 related articles for article (PubMed ID: 12968846)
1. Short- and medium-term increase of CA125 in peritoneal effluent using a neutral-pH solution.
García H; Hernández-Jaras J; Cruz Mdel C; Agramunt I; Calvo C; Cerrillo V
Perit Dial Int; 2003; 23(4):375-80. PubMed ID: 12968846
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study.
Pajek J; Kveder R; Bren A; Gucek A; Ihan A; Osredkar J; Lindholm B
Perit Dial Int; 2008; 28(1):44-52. PubMed ID: 18178947
[TBL] [Abstract][Full Text] [Related]
3. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
[TBL] [Abstract][Full Text] [Related]
4. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
5. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
[TBL] [Abstract][Full Text] [Related]
6. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
7. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
[TBL] [Abstract][Full Text] [Related]
8. Effects of ionized sodium concentrations on ultrafiltration rate in peritoneal dialysis using lactate and lactate/bicarbonate solutions.
La Milia V; Limardo M; Crepaldi M; Locatelli F
Perit Dial Int; 2009; 29(2):158-62. PubMed ID: 19293352
[TBL] [Abstract][Full Text] [Related]
9. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.
Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644
[TBL] [Abstract][Full Text] [Related]
11. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis.
Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW
Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237
[TBL] [Abstract][Full Text] [Related]
12. Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis.
Sanusi AA; Zweers MM; Weening JJ; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2001; 21(5):495-500. PubMed ID: 11757834
[TBL] [Abstract][Full Text] [Related]
13. Influence of pH-neutral peritoneal dialysis solution.
Moriishi M; Kawanishi H; Kawai T; Takahashi S; Hirai T; Shishida M; Watanabe H; Takahashi N
Adv Perit Dial; 2002; 18():68-71. PubMed ID: 12402590
[TBL] [Abstract][Full Text] [Related]
14. Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients.
Opatrná S; Pöpperlová A; Lysák D; Fuchsová R; Trefil L; Racek J; Topolčan O
Ther Apher Dial; 2016 Apr; 20(2):149-57. PubMed ID: 26929256
[TBL] [Abstract][Full Text] [Related]
15. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.
Akman S; van Westrhenen R; De Waart DR; Hiralall JK; Zweers MM; Krediet RT
Adv Perit Dial; 2003; 19():24-7. PubMed ID: 14763029
[TBL] [Abstract][Full Text] [Related]
16. Acidosis correction with a new 25 mmol/l bicarbonate/15 mmol/l lactate peritoneal dialysis solution.
Carrasco AM; Rubio MA; Sanchez Tommero JA; Fernandez Girón F; Gonzalez Rico M; del Peso Gilsanz G; Fernandez Perpén A; Ramón RG; Bueno IF; Tranaeus A; Faict D; Hopwood A
Perit Dial Int; 2001; 21(6):546-53. PubMed ID: 11783762
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells.
Plum J; Razeghi P; Lordnejad RM; Perniok A; Fleisch M; Fusshöller A; Schneider M; Grabensee B
Am J Kidney Dis; 2001 Oct; 38(4):867-75. PubMed ID: 11576893
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients.
Redahan L; Davenport A
J Nephrol; 2016 Jun; 29(3):427-434. PubMed ID: 26616639
[TBL] [Abstract][Full Text] [Related]
19. Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions.
Pajek J; Kveder R; Gucek A; Skoberne A; Bren A; Bucar M; Cerne D; Lukac-Bajalo J
Ther Apher Dial; 2010 Feb; 14(1):20-6. PubMed ID: 20438516
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions.
Opatrna S; Lysak D; Trefil L; Parker C; Topley N
Perit Dial Int; 2012; 32(1):37-44. PubMed ID: 22302924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
